These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 31889077)

  • 21. The diagnosis and treatment of hypertrophic cardiomyopathy.
    Prinz C; Farr M; Hering D; Horstkotte D; Faber L
    Dtsch Arztebl Int; 2011 Apr; 108(13):209-15. PubMed ID: 21505608
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Mode of splitting of the second heart sound in patients with hypertrophic cardiomyopathy].
    Fukuda N; Oki T; Sakai H; Asai M; Ohshima C; Kusaka Y; Tominaga T; Murao A; Niki T; Mori H
    J Cardiogr; 1983 Jun; 13(2):327-41. PubMed ID: 6687124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel Multiplexed Plasma Biomarker Panel Has Diagnostic and Prognostic Potential in Children With Hypertrophic Cardiomyopathy.
    Captur G; Doykov I; Chung SC; Field E; Barnes A; Zhang E; Heenan I; Norrish G; Moon JC; Elliott PM; Heywood WE; Mills K; Kaski JP
    Circ Genom Precis Med; 2024 Jun; 17(3):e004448. PubMed ID: 38847081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating Levels of MicroRNAs in Hypertrophic Cardiomyopathy: The Relationship With Left Ventricular Hypertrophy, Left Atrial Dilatation and Ventricular Depolarisation-Repolarisation Parameters.
    Sonsöz MR; Yilmaz M; Cevik E; Orta H; Bilge AK; Elitok A; Onur I; Komurcu-Bayrak E
    Heart Lung Circ; 2022 Feb; 31(2):199-206. PubMed ID: 34088630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circular RNA circZFPM2 regulates cardiomyocyte hypertrophy and survival.
    Neufeldt D; Schmidt A; Mohr E; Lu D; Chatterjee S; Fuchs M; Xiao K; Pan W; Cushman S; Jahn C; Juchem M; Hunkler HJ; Cipriano G; Jürgens B; Schmidt K; Groß S; Jung M; Hoepfner J; Weber N; Foo R; Pich A; Zweigerdt R; Kraft T; Thum T; Bär C
    Basic Res Cardiol; 2024 Aug; 119(4):613-632. PubMed ID: 38639887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pulsed Doppler echocardiographic assessment of diastolic left ventricular hemodynamics in hypertrophic cardiomyopathy: relationship between the mode of left ventricular filling and the distribution of left ventricular hypertrophy].
    Oki T; Asai M; Takemura H; Fukuda N; Sakai H; Tominaga T; Murao A; Ohshima C; Kusaka Y; Niki T
    J Cardiogr; 1983 Sep; 13(3):523-35. PubMed ID: 6687193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MiR-1-3p that correlates with left ventricular function of HCM can serve as a potential target and differentiate HCM from DCM.
    Li M; Chen X; Chen L; Chen K; Zhou J; Song J
    J Transl Med; 2018 Jun; 16(1):161. PubMed ID: 29885652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Higher copeptin levels are associated with worse outcome in patients with hypertrophic cardiomyopathy.
    Sahin I; Gungor B; Ozkaynak B; Uzun F; Küçük SH; Avci II; Ozal E; Ayça B; Cetın S; Okuyan E; Dinckal MH
    Clin Cardiol; 2017 Jan; 40(1):32-37. PubMed ID: 27768229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating Circular RNAs as Biomarkers for the Diagnosis and Prediction of Outcomes in Acute Ischemic Stroke.
    Zuo L; Zhang L; Zu J; Wang Z; Han B; Chen B; Cheng M; Ju M; Li M; Shu G; Yuan M; Jiang W; Chen X; Yan F; Zhang Z; Yao H
    Stroke; 2020 Jan; 51(1):319-323. PubMed ID: 31690252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Morphological Determinants of Obstructive Hypertrophic Cardiomyopathy Obtained Using Echocardiography.
    Nara I; Iino T; Watanabe H; Sato W; Watanabe K; Shimbo M; Umeta Y; Ito H
    Int Heart J; 2018 Mar; 59(2):339-346. PubMed ID: 29479008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Echocardiographic diagnosis of the different phenotypes of hypertrophic cardiomyopathy.
    Parato VM; Antoncecchi V; Sozzi F; Marazia S; Zito A; Maiello M; Palmiero P;
    Cardiovasc Ultrasound; 2016 Aug; 14(1):30. PubMed ID: 27519172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comprehensive Construction of a Circular RNA-Associated Competing Endogenous RNA Network Identified Novel Circular RNAs in Hypertrophic Cardiomyopathy by Integrated Analysis.
    Guo Q; Wang J; Sun R; He Z; Chen Q; Liu W; Wu M; Bao J; Liu Z; Wang J; Zhang Y
    Front Genet; 2020; 11():764. PubMed ID: 32849787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term outcome of nonobstructive versus obstructive hypertrophic cardiomyopathy: A systematic review and meta-analysis.
    Pelliccia F; Pasceri V; Limongelli G; Autore C; Basso C; Corrado D; Imazio M; Rapezzi C; Sinagra G; Mercuro G;
    Int J Cardiol; 2017 Sep; 243():379-384. PubMed ID: 28747036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Right ventricular obstruction in various types of hypertrophic cardiomyopathy.
    Stierle U; Sheikhzadeh A; Shakibi JG; Langbehn AF; Diederich KW
    Jpn Heart J; 1987 Jan; 28(1):115-25. PubMed ID: 3599397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blood circRNAs as biomarkers for the diagnosis of community-acquired pneumonia.
    Zhao T; Zheng Y; Hao D; Jin X; Luo Q; Guo Y; Li D; Xi W; Xu Y; Chen Y; Gao Z; Zhang Y
    J Cell Biochem; 2019 Oct; 120(10):16483-16494. PubMed ID: 31286543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased mean platelet volume in hypertrophic cardiomyopathy.
    Icli A; Aksoy F; Dogan A; Arslan A; Akcay S; Yücel H; Ersoy I; Gorgulu O
    Angiology; 2014 May; 65(5):420-4. PubMed ID: 23564022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypertrophy Regression With N-Acetylcysteine in Hypertrophic Cardiomyopathy (HALT-HCM): A Randomized, Placebo-Controlled, Double-Blind Pilot Study.
    Marian AJ; Tan Y; Li L; Chang J; Syrris P; Hessabi M; Rahbar MH; Willerson JT; Cheong BY; Liu CY; Kleiman NS; Bluemke DA; Nagueh SF
    Circ Res; 2018 Apr; 122(8):1109-1118. PubMed ID: 29540445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myocardial fibrosis in patients with symptomatic obstructive hypertrophic cardiomyopathy: correlation with echocardiographic measurements, sarcomeric genotypes, and pro-left ventricular hypertrophy polymorphisms involving the renin-angiotensin-aldosterone system.
    Blauwet LA; Ackerman MJ; Edwards WD; Riehle DL; Ommen SR
    Cardiovasc Pathol; 2009; 18(5):262-8. PubMed ID: 18835191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of left ventricular diastolic function by global strain rate imaging in patients with obstructive hypertrophic cardiomyopathy: a simultaneous speckle tracking echocardiography and cardiac catheterization study.
    Chen S; Yuan J; Qiao S; Duan F; Zhang J; Wang H
    Echocardiography; 2014 May; 31(5):615-22. PubMed ID: 24219240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of Myocardial Disarray in Patients With Hypertrophic Cardiomyopathy and Ventricular Arrhythmias.
    Ariga R; Tunnicliffe EM; Manohar SG; Mahmod M; Raman B; Piechnik SK; Francis JM; Robson MD; Neubauer S; Watkins H
    J Am Coll Cardiol; 2019 May; 73(20):2493-2502. PubMed ID: 31118142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.